iSpecimen, Inc. (ISPC)
1.49
-0.01
(-0.67%)
USD |
NASDAQ |
Sep 02, 16:00
1.50
+0.01
(+0.67%)
After-Hours: 20:00
iSpecimen Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | -0.70M |
| December 31, 2025 | 0.00 |
| September 30, 2025 | -1.00M |
| June 30, 2025 | -0.0005M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.0731M |
| September 30, 2024 | -0.18M |
| June 30, 2024 | 0.2951M |
| March 31, 2024 | 1.937M |
| December 31, 2023 | -0.723M |
| September 30, 2023 | 2.351M |
| June 30, 2023 | -0.068M |
| March 31, 2023 | -8.788M |
| Date | Value |
|---|---|
| December 31, 2022 | -1.642M |
| September 30, 2022 | -0.7721M |
| June 30, 2022 | -0.438M |
| March 31, 2022 | -0.3392M |
| December 31, 2021 | -0.3042M |
| September 30, 2021 | -0.2908M |
| June 30, 2021 | -0.2283M |
| March 31, 2021 | -0.2145M |
| December 31, 2020 | -0.2367M |
| September 30, 2020 | -0.2739M |
| June 30, 2020 | -0.3318M |
| March 31, 2020 | -0.2602M |
| December 31, 2019 | -0.356M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| LataMed AI Corp. | 0.00 |
| SCWorx Corp. | -0.0726M |
| Health Catalyst, Inc. | 0.902M |
| GoodRx Holdings, Inc. | -14.41M |
| Claritev Corp. | -38.08M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.6896M |
| Cash from Financing (Quarterly) | 2.285M |
| Free Cash Flow | -8.704M |
| Free Cash Flow Per Share (Quarterly) | -0.4945 |
| Free Cash Flow to Equity (Quarterly) | -0.6755M |
| Free Cash Flow to Firm (Quarterly) | -0.6896M |
| Free Cash Flow Yield | -1.12K% |